NEWS

Medsafe Approves Trientine Tetrahydrochloride (Cuprior) for the Treatment Of Wilson's Disease

Nov 26, 2021

Medsafe Approves Trientine Tetrahydrochloride (Cuprior) for the Treatment Of Wilson's Disease

Te Arai BioFarma are happy to announce that Medsafe has approved an innovative new treatment for Wilson's Disease, trientine...

PHARMAC funds new medicine MacroBID®

Oct 29, 2020

PHARMAC funds new medicine MacroBID®

PHARMAC today announced their decision to fund MacroBID® modified release nitrofurantoin capsules. MacroBID® is a modified release...

New Antibiotic registered to treat Urinary Tract Infections (UTI)

Sep 30, 2020

New Antibiotic registered to treat Urinary Tract Infections (UTI)

MacroBID® is a new antibiotic medicine Medsafe registered by Te Arai BioFarma. MacroBID® is a modified release nitrofurantoin containing...

1

2 3 4 5